XW7-10552-66729 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-19
Dose 1 — Pfizer-BioNTech
2021-04-09
Dose 2 — Pfizer-BioNTech
2021-11-30
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-12-01
Registered in v-safe
2021-12-01
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-02
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Muscle or body aches

Free text: Very swollen lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2021-12-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fever · Headache

Adult check-in
2021-12-04
Survey response — days 1–6 daily, dose 3
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good

Free text: Lymph nodes still very swollen but less painful

MedDRA releases: 2024-11 · check-in free text available
2021-12-05
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Lymph nodes still somewhat swollen

MedDRA releases: 2024-11 · check-in free text available
2021-12-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-07
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-14
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-21
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-28
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-04
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-11
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-01
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-31
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-30
Survey response — 12 months, dose 3
MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Gave birth

MedDRA releases: 2024-11 · check-in free text available
2022-11-30
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-12-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-19	Pfizer-BioNTech	No
2	2021-04-09	Pfizer-BioNTech	No
3	2021-11-30	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-11-30	Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-02

Systemic reaction (other): Very swollen lymph nodes

2021-12-04

Systemic reaction (other): Lymph nodes still very swollen but less painful

2021-12-05

Systemic reaction (other): Lymph nodes still somewhat swollen

Release 12 — 12 months, dose 3

2022-11-30

Symptoms: Gave birth

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Delivery	·	·	✓
SRO	Lymph node pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release